Page 11 - Sk Bioscience Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sk bioscience co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sk Bioscience Co Today - Breaking & Trending Today

South Korea to begin producing Novavax COVID-19 vaccine as early as June


2 Min Read
SEOUL (Reuters) - South Korea said on Monday it plans to begin local production of Novavax Inc’s COVID-19 vaccine as early as June, while five domestic companies aim to start late stage clinical trials of their own shots in the second half of this year.
FILE PHOTO: A woman holds a small bottle labelled with a Coronavirus COVID-19 Vaccine sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic
The announcements came after President Moon Jae-in hosted a special meeting on anti-virus efforts and vaccine development as the country fears a possible fourth wave of infections. ....

South Korea , Soult Ukpyolsi , David Goodman , Catherine Evans , Hyonhee Shin , Kirsten Donovan , Kwon Deok Cheol , Sk Bioscience Co , Thomson Reuters Trust Principles , Genexine Inc , Prevention Agency , Cellid Co , Eubiologics Co , Novavax Inc , President Moon Jae In , Minister Kwon Deok Cheol , Geneone Life , Korea Disease Control , Thomson Reuters Trust , Corona Virus , Asia Pacific , Communicable Diseases , East Asia , Emerging Market Countries , General News , General Health ,

S.Korean companies begin COVID-19 vaccine trials -Yonhap


Article content
SEOUL Five South Korean companies have launched clinical trials for their coronavirus vaccines, aiming to enter the third phase of trials in the second half of this year, the health ministry said on Monday.
The five are SK Bioscience Co, EuBiologics Co , Cellid Co, Genexine Inc and GeneOne Life Science.
We apologize, but this video has failed to load.
Try refreshing your browser, or
S.Korean companies begin COVID-19 vaccine trials -Yonhap Back to video
The government plans to provide 68.7 billion won ($61.1 million) to support the companies’ vaccine development, the ministry said in a statement.
The ministry also said that SK Bioscience will be able to begin manufacturing COVID-19 vaccines developed by Novavax Inc as early as June, which it said would ease any potential supply shortages in the face of global production delays. ....

Soult Ukpyolsi , South Korea , South Korean , David Goodman , Catherine Evans , Cellid Co , Sk Bioscience Co , Genexine Inc , Novavax Inc , Eubiologics Co , Five South Korean , Geneone Life , Hyonhee Shin Editing , தெற்கு கொரியா , தெற்கு கொரியன் , டேவிட் நல்ல மனிதன் , கேத்தரின் எவன்ஸ் , ஸ்க் உயிர் அறிவியல் இணை , ஐந்து தெற்கு கொரியன் ,

UPDATE 1-S.Korean companies begin COVID-19 vaccine trials -Yonhap


UPDATE 2-S.Korea to begin producing Novavax COVID-19 vaccine as early as June
Reuters
1 hr ago
Popular Searches
Restrictions introduced as fears of fourth wave grow (Adds quotes, new case numbers, background)
By Hyonhee Shin
SEOUL, April 12 (Reuters) - South Korea said on Monday it plans to begin local production of Novavax Inc s COVID-19 vaccine as early as June, while five domestic companies aim to start late stage clinical trials of their own shots in the second half of this year.
The announcements came after President Moon Jae-in hosted a special meeting on anti-virus efforts and vaccine development as the country fears a possible fourth wave of infections. ....

Soult Ukpyolsi , South Korea , South Korean , David Goodman , Catherine Evans , Hyonhee Shin , Cellid Co , Sk Bioscience Co , Genexine Inc , Novavax Inc , Eubiologics Co , Geneone Life , Hyonhee Shin Editing , தெற்கு கொரியா , தெற்கு கொரியன் , டேவிட் நல்ல மனிதன் , கேத்தரின் எவன்ஸ் , ஸ்க் உயிர் அறிவியல் இணை ,